Session Details

MSC Workshop Session 1 - Clinical Trials Part I: MSC Sources, Applications and 'Off the Shelf' Products
Wednesday, May 29, 2019 08:30 AM - 10:00 AM
Room 219
Chair: Yufang Shi, PhD, Institutes for Translational Medicine, China

Commercial Scale Manufacturing Using Next Generation Technologies to Meet Peak Market Demand for Approved Cell Therapies
Paul Simmons, PhD, Mesoblast, Australia

iPSC-Derived Mesenchymal and Vascular Progenitor: A Novel Technology Platform for Regenerative Medicine
Igor Slukvin,MD, PhD, University of Wisconsin, United States

Clinical Development of MultiStem®, an Adult Stem Cell Therapy, for Treatment of Acute Injuries of the Central Nervous System
Robert W. Mays,PhD, Athersys Inc., United States